Analyst Ratings for Amneal Pharmaceuticals (AMRX)

AMRX Rating Summary

AMRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AMRX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $6.06 (-93.5%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 56%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2021 RBC Capital Daniel Busb New Coverage Sector Perform
(N/A)
5.00
(N/A)
0.08
(92.80)
115900% Details
3/8/2021 Goldman Sachs Nathan Rich Upgrade Buy
(Sell)
6.50
(4.00)
4.95
(92.80)
1774.75% Details
Like AMRX Ratings? Also take a look at TEVA, PHAT, VNDA, SPB

AMRX Ratings News